Document Detail

Kaposi's sarcoma in rheumatic diseases.
MedLine Citation:
PMID:  12701043     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To review the clinical features and outcome of all reported cases of Kaposi's sarcoma in patients with rheumatic diseases. METHODS: In addition to our patient, we identified cases from a Medline search between the years 1966 and 2002. Cases associated with human immunodeficiency virus infection were excluded. RESULTS: Including our patient, there were a total of 25 cases reported (11 men and 14 women). Rheumatoid arthritis was present in 8 cases, polymyositis/dermatomyositis in 5, vasculitis syndromes in 5, systemic lupus erythematosus in 3, polymyalgia rheumatica in 2, and 1 each of undifferentiated connective tissue disease and Behcet disease. All but 1 patient had been given systemic corticosteroids for a duration that ranged from 6 weeks to 22 years, and immunosuppressive drugs from 25 days to 3.5 years. The Kaposi's lesions usually involved the skin on the extremities; internal organ involvement occurred in 7 cases. Most lesions responded to a decreasing dosage of corticosteroids and immunosuppressive drugs, or to the administration of radiation or cytotoxic therapy. Six patients died, 4 of which were related to the progression of Kaposi's sarcoma. CONCLUSION: Kaposi's sarcoma in patients with rheumatologic conditions is rare. The clinical features are similar to those with classical Kaposi's sarcoma. Tumor regression usually occurs with decreasing corticosteroids and/or immunosuppressive drugs, local irradiation, or cytotoxic therapy.
Worawit Louthrenoo; Nuntana Kasitanon; Pongsak Mahanuphab; Lertlakana Bhoopat; Sumitra Thongprasert
Related Documents :
9767453 - Amidolytic and peptidolytic activities of immunoglobulin g present in sera from patient...
9972963 - Quality of life in systemic lupus erythematosus: a controlled study.
10101583 - The cause and management of bladder, sexual and bowel symptoms in multiple sclerosis.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Seminars in arthritis and rheumatism     Volume:  32     ISSN:  0049-0172     ISO Abbreviation:  Semin. Arthritis Rheum.     Publication Date:  2003 Apr 
Date Detail:
Created Date:  2003-04-17     Completed Date:  2003-08-26     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  1306053     Medline TA:  Semin Arthritis Rheum     Country:  United States    
Other Details:
Languages:  eng     Pagination:  326-33     Citation Subset:  IM    
Copyright Information:
Copyright 2003, Elsevier Inc. All rights reserved.
Division of Rheumatology, Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Anti-Inflammatory Agents / therapeutic use*
Antineoplastic Agents / therapeutic use*
Immunosuppressive Agents / therapeutic use*
Middle Aged
Rheumatic Diseases / complications*,  drug therapy
Sarcoma, Kaposi / complications*,  drug therapy*
Treatment Outcome
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Antineoplastic Agents; 0/Immunosuppressive Agents; 0/Steroids
Comment In:
Semin Arthritis Rheum. 2004 Apr;33(5):352; author reply 352-3   [PMID:  15079765 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Outcome of posttraumatic fibromyalgia: a 3-year follow-up of 78 cases of cervical spine injuries.
Next Document:  Arthritis and interstitial granulomatous dermatitis (Ackerman syndrome) with pulmonary silicosis.